Please login to the form below

Not currently logged in
Email:
Password:

Handl Therapeutics

This page shows the latest Handl Therapeutics news and features for those working in and with pharma, biotech and healthcare.

UCB boosts gene therapy offering with a pair of new deals

UCB boosts gene therapy offering with a pair of new deals

Handl Therapeutics – based in Leuven, Belgium – specialises in adeno-associated virus (AAV) capsid technology and has a focus on developing disease modifying gene therapies to treat neurodegenerative diseases. ... the development of gene therapies

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...